Document is current
Any future updates will be listed below
-
Authors
Kallert, Sandra M.
Darbre, Stephanie
Bonilla, Weldy V.
Kreutzfeldt, Mario
Page, Nicolas
Müller, Philipp
Kreuzaler, Matthias
Lu, Min
Favre, Stéphanie
Kreppel, Florian
Löhning, Max
Luther, Sanjiv A.
Zippelius, Alfred
Merkler, Doron
Pinschewer, Daniel D. https://orcid.org/0000-0002-1594-3189
- License Information
-
More Information
Article History
Received: 2 November 2016
Accepted: 22 March 2017
First Online: 26 May 2017
Competing interests
: D.D.P. is a shareholder and also a consultant to Hookipa Biotech AG commercializing arenavirus-based vector technology. S.M.K., S.D., MarK, N.P., D.M. and D.D.P. are listed as inventors on a patent entitled ‘Tri-segmented arenaviruses as vaccine vectors’ (application number PCT/EP2015/076458) describing artLCMV-based vector technology. The remaining authors declare no competing financial interests.
